{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:29:41Z","timestamp":1757618981080,"version":"3.44.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11337-z","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T06:49:19Z","timestamp":1752562159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic changes of chronic hepatitis B patient with loss of surface antigen: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Chong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Peng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"7","key":"11337_CR1","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/v14071504","volume":"14","author":"C Saitta","year":"2022","unstructured":"Saitta C, Pollicino T, Raimondo G. Occult hepatitis B virus infection: an update. Viruses. 2022;14(7):1504.","journal-title":"Viruses."},{"key":"11337_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12072-021-10285-5","volume":"16","author":"M Kumar","year":"2022","unstructured":"Kumar M, Abbas Z, Azami M, Belopolskaya M, Dokmeci AK, Ghazinyan H, et al. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy. Hepatol Int. 2022;16:211\u201353 United States.","journal-title":"Hepatol Int"},{"issue":"1","key":"11337_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.acvd.2015.08.005","volume":"109","author":"R Bacquelin","year":"2016","unstructured":"Bacquelin R, Oger E, Filippi E, Hacot JP, Auffret V, Le Guellec M, et al. Safety of Prasugrel in real-world patients with ST-segment elevation myocardial infarction: 1-year results from a prospective observational study (Bleeding and myocardial infarction Study). Arch Cardiovasc Dis. 2016;109(1):31\u20138.","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"11337_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","volume":"71","author":"G Raimondo","year":"2019","unstructured":"Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71(2):397\u2013408.","journal-title":"J Hepatol"},{"issue":"2","key":"11337_CR5","doi-asserted-by":"publisher","first-page":"e17126","DOI":"10.5812\/jjm.17126","volume":"8","author":"S Zhand","year":"2015","unstructured":"Zhand S, Karami C, Hosseinzadeh Adli A, Tabarraei A, Khodabakhshi B, Moradi A. Correlation between hepatitis B G1896A precore mutations and hbeag in chronic HBV patients. Jundishapur J Microbiol. 2015;8(2):e17126.","journal-title":"Jundishapur J Microbiol"},{"issue":"30","key":"11337_CR6","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.4254\/wjh.v7.i30.2980","volume":"7","author":"L Wang","year":"2015","unstructured":"Wang L, Wang K, Zou ZQ. Crosstalk between innate and adaptive immunity in hepatitis B virus infection. World J Hepatol. 2015;7(30):2980\u201391.","journal-title":"World J Hepatol"},{"key":"11337_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1471-2180-12-307","volume":"12","author":"D Zhang","year":"2012","unstructured":"Zhang D, Dong P, Zhang K, Deng L, Bach C, Chen W, et al. Whole genome HBV deletion profiles and the accumulation of pres deletion mutant during antiviral treatment. BMC Microbiol. 2012;12:307.","journal-title":"BMC Microbiol"},{"issue":"12","key":"11337_CR8","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.3390\/biomedicines10123202","volume":"10","author":"D T\u00fcmen","year":"2022","unstructured":"T\u00fcmen D, Heumann P, G\u00fclow K, Demirci CN, Cosma LS, M\u00fcller M, et al. Pathogenesis and current treatment strategies of hepatocellular carcinoma. Biomedicines. 2022;10(12):3202.","journal-title":"Biomedicines."},{"issue":"9","key":"11337_CR9","doi-asserted-by":"publisher","first-page":"e29894","DOI":"10.1002\/jmv.29894","volume":"96","author":"Z Lv","year":"2024","unstructured":"Lv Z, Liu L, You J, Zhou P, Su Y, Zhao K, et al. Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429-dependent m6A modification of CCR9. J Med Virol. 2024;96(9):e29894.","journal-title":"J Med Virol"},{"issue":"3","key":"11337_CR10","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s12072-010-9249-4","volume":"5","author":"S Ogasawara","year":"2011","unstructured":"Ogasawara S, Kanai F, Obi S, Sato S, Yamaguchi T, Azemoto R, et al. Safety and tolerance of Sorafenib in Japanese patients with advanced hepatocellular carcinoma. Hepatol Int. 2011;5(3):850\u20136.","journal-title":"Hepatol Int"},{"issue":"6","key":"11337_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S2468-1253(18)30078-5","volume":"3","author":"M Kudo","year":"2018","unstructured":"Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N, et al. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus Sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. Lancet Gastroenterol Hepatol. 2018;3(6):424\u201332.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"11337_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jhep.2014.04.036","volume":"61","author":"T Pollicino","year":"2014","unstructured":"Pollicino T, Raimondo G. Occult hepatitis B infection. J Hepatol. 2014;61(3):688\u20139.","journal-title":"J Hepatol"},{"issue":"6","key":"11337_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1440-1746.2002.02737.x","volume":"17","author":"JH Kao","year":"2002","unstructured":"Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol. 2002;17(6):643\u201350.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"11337_CR14","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.4254\/wjh.v7.i8.1086","volume":"7","author":"S Gao","year":"2015","unstructured":"Gao S, Duan ZP, Coffin CS. Clinical relevance of hepatitis B virus variants. World J Hepatol. 2015;7(8):1086\u201396.","journal-title":"World J Hepatol"},{"issue":"10","key":"11337_CR15","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1136\/gut.2003.033324","volume":"53","author":"HLY Chan","year":"2004","unstructured":"Chan HLY, Hui AY, Wong ML, Tse AML, Hung LCT, Wong VWS, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut. 2004;53(10):1494\u20138.","journal-title":"Gut"},{"issue":"10","key":"11337_CR16","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/jmv.23640","volume":"85","author":"X Li","year":"2013","unstructured":"Li X, Liu Y, Xu Z, Wan Z, Bai S, Mao P, et al. A complete genomic analysis of hepatitis B virus isolated from 516 Chinese patients with different clinical manifestations. J Med Virol. 2013;85(10):1698\u2013704.","journal-title":"J Med Virol"},{"issue":"24","key":"11337_CR17","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.3748\/wjg.v20.i24.7644","volume":"20","author":"A Alexopoulou","year":"2014","unstructured":"Alexopoulou A, Karayiannis P. HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection. World J Gastroenterol. 2014;20(24):7644\u201352.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"11337_CR18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1128\/JVI.80.3.1405-1413.2006","volume":"80","author":"Z Hu","year":"2006","unstructured":"Hu Z, Zhang Z, Kim JW, Huang Y, Liang TJ. Altered proteolysis and global gene expression in hepatitis B virus X Transgenic mouse liver. J Virol. 2006;80(3):1405\u201313.","journal-title":"J Virol"},{"issue":"Suppl 3","key":"11337_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3851\/IMP1619","volume":"15","author":"S Locarnini","year":"2010","unstructured":"Locarnini S, Zoulim F. Molecular genetics of HBV infection. Antivir Ther. 2010;15(Suppl 3):3\u201314.","journal-title":"Antivir Ther"},{"issue":"2","key":"11337_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.gastro.2012.05.002","volume":"143","author":"MW Lai","year":"2012","unstructured":"Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, et al. Increased Seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Gastroenterology. 2012;143(2):400\u20137.","journal-title":"Gastroenterology"},{"issue":"18","key":"11337_CR21","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.3748\/wjg.v20.i18.5435","volume":"20","author":"T Shen","year":"2014","unstructured":"Shen T, Yan XM. Hepatitis B virus genetic mutations and evolution in liver diseases. World J Gastroenterol. 2014;20(18):5435\u201341.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"11337_CR22","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.aohep.2023.101156","volume":"29","author":"M Bubonja-\u0160onje","year":"2024","unstructured":"Bubonja-\u0160onje M, Peru\u010d D, Abram M, Mohar-Vitezi\u0107 B. Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in Western Croatia. Ann Hepatol. 2024;29(1):101156.","journal-title":"Ann Hepatol"},{"issue":"RR\u201316","key":"11337_CR23","first-page":"1","volume":"54","author":"EE Mast","year":"2005","unstructured":"Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the united states: recommendations of the advisory committee on immunization practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2005;54(RR\u201316):1\u201331.","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"issue":"1","key":"11337_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/v16010071","volume":"16","author":"AS Damiani","year":"2023","unstructured":"Damiani AS, Holzmayer V, Galli C, De Nuzzo M, Anderson M, Cloherty G, et al. Serological and molecular characterization of occult HBV infection in blood donors from South Italy. Viruses. 2023;16(1):71.","journal-title":"Viruses."},{"issue":"9","key":"11337_CR25","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10096-015-2422-x","volume":"34","author":"RAA Pond\u00e9","year":"2015","unstructured":"Pond\u00e9 RAA. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2015;34(9):1709\u201331.","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"issue":"2","key":"11337_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","volume":"61","author":"T Pollicino","year":"2014","unstructured":"Pollicino T, Cacciola I, Saffioti F, Raimondo G. Hepatitis B virus pres\/s gene variants: pathobiology and clinical implications. J Hepatol. 2014;61(2):408\u201317.","journal-title":"J Hepatol"},{"key":"11337_CR27","doi-asserted-by":"publisher","first-page":"104925","DOI":"10.1016\/j.antiviral.2020.104925","volume":"182","author":"S Tsukuda","year":"2020","unstructured":"Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral Res. 2020;182:104925.","journal-title":"Antiviral Res"},{"issue":"2","key":"11337_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/carcin\/bgr296","volume":"33","author":"LHC Wang","year":"2012","unstructured":"Wang LHC, Huang W, Lai MD, Su IJ. Aberrant Cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis. Carcinogenesis. 2012;33(2):466\u201372.","journal-title":"Carcinogenesis"},{"issue":"45","key":"11337_CR29","doi-asserted-by":"publisher","first-page":"46384","DOI":"10.1074\/jbc.M403568200","volume":"279","author":"JH Hung","year":"2004","unstructured":"Hung JH, Su IJ, Lei HY, Wang HC, Lin WC, Chang WT, et al. Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J Biol Chem. 2004;279(45):46384\u201392.","journal-title":"J Biol Chem"},{"issue":"10","key":"11337_CR30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1158\/1541-7786.MCR-07-0098","volume":"5","author":"YH Hsieh","year":"2007","unstructured":"Hsieh YH, Su IJ, Wang HC, Tsai JH, Huang YJ, Chang WW, et al. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1. Mol Cancer Res. 2007;5(10):1063\u201372.","journal-title":"Mol Cancer Res"},{"key":"11337_CR31","doi-asserted-by":"crossref","unstructured":"Svicher V, Cento V, Bernassola M, Neumann-Fraune M, Van Hemert F, et al. Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. Antiviral Res. 2012;93(1):86\u201393.","DOI":"10.1016\/j.antiviral.2011.10.022"},{"issue":"3","key":"11337_CR32","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/hep.510290352","volume":"29","author":"HL Chan","year":"1999","unstructured":"Chan HL, Hussain M, Lok AS. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology. 1999;29(3):976\u201384.","journal-title":"Hepatology"},{"issue":"12","key":"11337_CR33","first-page":"1361","volume":"7","author":"HLY Chan","year":"2009","unstructured":"Chan HLY, Wong GLH, Tse CH, Chim AML, Yiu KKL, Chan HY, et al. Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B. clin gastroenterol hepatol off clin pract. J Am Gastroenterol Assoc. 2009;7(12):1361\u20136.","journal-title":"J Am Gastroenterol Assoc"},{"issue":"4","key":"11337_CR34","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2012.05.009","volume":"57","author":"CH Huang","year":"2012","unstructured":"Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, et al. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol. 2012;57(4):720\u20139.","journal-title":"J Hepatol"},{"issue":"3\u20134","key":"11337_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000360943","volume":"57","author":"G Raimondo","year":"2014","unstructured":"Raimondo G, Filomia R, Maimone S. Therapy of occult hepatitis B virus infection and prevention of reactivation. Intervirology. 2014;57(3\u20134):189\u201395.","journal-title":"Intervirology"},{"key":"11337_CR36","doi-asserted-by":"publisher","first-page":"582504","DOI":"10.3389\/fonc.2020.582504","volume":"10","author":"S Liu","year":"2020","unstructured":"Liu S, Lai J, Lyu N, Xie Q, Cao H, Chen D, et al. Effects of antiviral therapy on HBV reactivation and survival in hepatocellular carcinoma patients undergoing hepatic artery infusion chemotherapy. Front Oncol. 2020;10:582504.","journal-title":"Front Oncol"},{"key":"11337_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.freeradbiomed.2024.01.011","volume":"213","author":"J Yang","year":"2024","unstructured":"Yang J, Zheng L, Yang Z, Wei Z, Shao J, Zhang Y, et al. 5-FU promotes HBV replication through oxidative stress-induced autophagy dysfunction. Free Radic Biol Med. 2024;213:233\u201347.","journal-title":"Free Radic Biol Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11337-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:29:20Z","timestamp":1757248160000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11337-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11337"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11337-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"15 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details along with any identifying images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"918"}}